TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
St1 Biokraft AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
26,626
|
299,453
|
245,047 |
| Financial expenses |
63,551
|
77,807
|
39,418 |
| Earnings before taxes |
-274,610
|
-115,767
|
-63,729 |
| EBITDA |
-40,393
|
15,041
|
12,553 |
| Total assets |
1,260,560
|
1,317,569
|
1,252,358 |
| Current assets |
138,038
|
297,509
|
433,935 |
| Current liabilities |
235,102
|
236,080
|
172,122 |
| Equity capital |
468,327
|
389,522
|
496,394 |
| - share capital |
56,605
|
58,542
|
58,242 |
| Employees (average) |
45
|
115
|
105 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
37.2%
|
29.6%
|
39.6% |
| Turnover per employee |
592
|
2,604
|
2,334 |
| Profit as a percentage of turnover |
-1031.4%
|
-38.7%
|
-26.0% |
| Return on assets (ROA) |
-16.7%
|
-2.9%
|
-1.9% |
| Current ratio |
58.7%
|
126.0%
|
252.1% |
| Return on equity (ROE) |
-58.6%
|
-29.7%
|
-12.8% |
| Change turnover | |||
| Change turnover % |
22%
|
-7% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
10%
|
-4% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.